Related Experiment Video

Updated: Oct 13, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

334

RAF1 amplification: an exemplar of MAPK pathway activation in urothelial carcinoma

Sean Clark-Garvey1, William Y Kim1,2,3,4

  • 1Division of Oncology, Department of Medicine.

The Journal of Clinical Investigation
|November 15, 2021
PubMed

Insights

Researchers discovered a RAF1 amplification subtype in muscle-invasive bladder cancer (MIBC). RAF1 inhibition showed efficacy in preclinical models, highlighting the MAPK pathway

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Advanced bladder cancer presents poor survival rates despite recent therapeutic advancements.
  • Molecular heterogeneity in bladder cancer necessitates identification of novel driver alterations.
  • Targeted therapies, like FGFR inhibitors, show promise but further discoveries are crucial.

Purpose of the Study:

  • To identify novel genetic alterations driving muscle-invasive bladder cancer (MIBC).
  • To investigate the therapeutic potential of targeting RAF1 in bladder cancer.
  • To elucidate the role of the MAPK pathway in bladder tumorigenesis.

Main Methods:

  • Genomic analysis to identify driver genetic alterations in bladder cancer subtypes.
  • Preclinical testing of RAF1 inhibitors and combination therapies (RAF1/MEK inhibitors).
  • Evaluation of therapeutic efficacy in relevant preclinical models.

Main Results:

  • Identification of a distinct MIBC subtype characterized by RAF1 amplification.
  • Demonstration of efficacy for RAF1 inhibition and RAF1/MEK inhibition in preclinical models with RAF1 amplifications.
  • Validation of efficacy in tumors with HRAS and NRAS mutations.

Conclusions:

  • RAF1 amplification is a significant driver event in bladder cancer.
  • The MAPK pathway plays a central role in bladder cancer development.
  • RAF1 and MEK inhibition represent potential therapeutic strategies for specific bladder cancer subtypes.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.2K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.4K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
13.3K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K